Covid-19InterviewDECN Files Provisional Patent For Genviro! Professional Covid-19 :15 Swift Kit: Interview
Decision Diagnostics Corp. (OTC PINK:DECN) through its subsidiary Pharma Tech Solutions, Inc., announced it has filed a provisional patent for its Genviro! Swift Professional product titled, “Method and Apparatus for Swift Determination of the Covid-19 Virus.” In so doing, the company is unveiling its Hematocrit adjustment feature, initially developed for its GenUltimate TBG system. To learn more, we conducted an interview with Keith Berman, CEO Decision Diagnostics. 1. Can you tell us more about Decision...










